EIX vs IRD · P/E 7.3, rev $17.60B vs rev $11.0M
Edison International (EIX) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. IRD currently screens at market cap $35.7M.
Not investment advice. Open the EIX and IRD stock pages for the full models.
Not investment advice.